results from a previously reported placebo-controlled trial of fluvoxamine in 42 patients with obsessive-compulsive disorder showed that the yale-brown scale was sensitive to drug-induced changes and that reductions in yale-brown scale scores specifically reflected improvement in obsessive-compulsive disorder symptoms .
C0085228
fluvoxamine
C0028768
obsessive-compulsive disorder